Plasma tau, neurofilament light chain and amyloid-β levels and risk of dementia; a population-based cohort study

CSF biomarkers, including total-tau, neurofilament light chain (NfL) and amyloid-β, are increasingly being used to define and stage Alzheimer’s disease. These biomarkers can be measured more quickly and less invasively in plasma and may provide important information for early diagnosis of Alzheimer’...

Descripción completa

Detalles Bibliográficos
Autores principales: de Wolf, Frank, Ghanbari, Mohsen, Licher, Silvan, McRae-McKee, Kevin, Gras, Luuk, Weverling, Gerrit Jan, Wermeling, Paulien, Sedaghat, Sanaz, Ikram, M Kamran, Waziry, Reem, Koudstaal, Wouter, Klap, Jaco, Kostense, Stefan, Hofman, Albert, Anderson, Roy, Goudsmit, Jaap, Ikram, M Arfan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7174054/
https://www.ncbi.nlm.nih.gov/pubmed/32206776
http://dx.doi.org/10.1093/brain/awaa054

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7174054/
https://www.ncbi.nlm.nih.gov/pubmed/32206776
http://dx.doi.org/10.1093/brain/awaa054

Ejemplares similares